| Lindsay Australia Limited (LAU) ORDINARY FULLY PAID |
Industrials |
$220 |
Change in substantial holding from SOL
|
30 Jul 2024 9:02AM |
$0.910 |
$0.695 |
fallen by
23.63%
|
|
| Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$15,277 |
Change in substantial holding for LAU
|
30 Jul 2024 9:02AM |
$35.120 |
$41.530 |
risen by
18.25%
|
|
| Peako Limited (PKO) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2024 9:02AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
PKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration focused on East Kimberley region, Western Australia.
- Koongie Park Formation shows prospectivity for base and precious metals.
- Eastman Ultramafic Intrusion shows potential for base and precious metals.
- Eastman PGE Project targets a major PGE resource within a large, underexplored intrusive complex.
- Exploration results confirm PGE mineralisation beyond chromite lenses.
- Corporate changes announced, including new board appointments.
- Fully underwritten entitlement offer launched to raise $1.054 million.
- Cash flows indicate a net decrease in cash equivalents for the period.
- Payments to related parties and their associates included in the report.
- No new tenements acquired or disposed of during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,175 |
Trading Halt
|
30 Jul 2024 9:02AM |
$2.340 |
$2.450 |
risen by
4.70%
|
|
PGF - Price-sensitive ASX Announcement
Full Release
Key Points
- PGF requested a trading halt pending a capital raising announcement.
- The trading halt will remain until the commencement of normal trading on August 1, 2024, or until an announcement is made.
- The capital raising includes a placement to wholesale and sophisticated investors and a Share Purchase Plan for eligible shareholders.
- PGF expects to end the trading halt with an announcement about the completion of the Placement.
- PGF is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,747 |
Update on oilseed crush feasibility study
|
30 Jul 2024 9:01AM |
$8.860 |
$7.860 |
fallen by
11.29%
|
|
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities and Cash Flow Reports 30 June 2024
|
30 Jul 2024 9:01AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of remaining 49% of Narraburra Rare Earth Element Project.
- Third phase of metallurgical testing underway for Narraburra.
- Completion of placement and entitlement offers raises $1,236,000.
- New exploration targets identified at Narraburra.
- New gold-copper soil anomaly found at Spring Creek Prospect within Copper Hill East project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,164 |
Weekly NTA - 26 July 2024
|
30 Jul 2024 9:00AM |
$5.200 |
$5.410 |
risen by
4.04%
|
|
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$9 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2024 9:00AM |
$0.145 |
$0.037 |
fallen by
74.48%
|
|
QEM - Price-sensitive ASX Announcement
Full Release
Key Points
- 2024 Scoping Study nearing completion
- Collaboration with The University of Queensland Sustainable Minerals Institute continues
- Grant application submitted for Vanadium Recovery Project
- Tenth consecutive ESG Report released
- Julia Creek Project is a significant vanadium and oil shale resource
- Significant advancements in JCP Scoping Study with RPM Global
- Material characterisation agreement with The University of Queensland
- Vanadium Beneficiation Test work undertaken by Core Resources
- Plans for a new exploration campaign at Julia Creek
- Environmental monitoring and surface water surveys conducted
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adacel Technologies Limited (ADA) ORDINARY FULLY PAID |
Information Technology |
- |
FY24 Results Conference Call
|
30 Jul 2024 8:59AM |
$0.485 |
$0.475 |
fallen by
2.06%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$65 |
Completion of Placement and Institutional Entitlement Offer
|
30 Jul 2024 8:59AM |
$0.485 |
$0.575 |
risen by
18.56%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- No shareholder approval is required for the issue of New Shares under the Institutional Offer.
- New Shares will settle on 5 August 2024 and be issued on 6 August 2024.
- The Offer is fully underwritten and led by Bell Potter Securities Limited.
- Institutional Offer to raise approximately A$6.9 million; Retail Entitlement Offer around A$3.1 million.
- Retail Entitlement Offer opens on 2 August 2024 and closes on 22 August 2024.
- Eligible retail shareholders can subscribe for 1 New Share per 7.35 existing ordinary shares at A$0.38 per share.
- Retail shareholders can apply for additional shares under a 'top up' facility.
- Key dates include trading halt on 26 July 2024, record date on 30 July 2024, and various settlement and issuance dates in August 2024.
- Bell Potter Securities Limited serves as Lead Manager and underwriter for the Offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Activities Report
|
30 Jul 2024 8:59AM |
$0.019 |
$0.008 |
fallen by
57.89%
|
|
LIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lion Energy signed a 20-year lease agreement with the Port of Brisbane to build and operate its first green hydrogen refuelling hub.
- Negotiations with prospective joint venture partners for the green hydrogen strategy are near finalization.
- Lion has received strong interest for leasing its newly acquired hydrogen tube trailers.
- The company successfully raised $1,600,000 in capital from key shareholders.
- Lion was granted a 4-year extension of the East Seram PSC, retaining key prospects and leads in a new area effective from 17 July 2024.
- A crude oil lifting on 30 June 2024 provided Lion with proceeds of approximately USD 235,000 post government entitlement.
- Lion continues to advance joint venture discussions and expects to announce its first green hydrogen offtake contract in Q3 2024.
- The green hydrogen facility at the Port of Brisbane is designed to support public bus fleets, off-grid power for construction and mining sectors, and industrial users.
- Lion Energy has secured procurement agreements for key equipment like electrolysers and refuelling packages for the Port of Brisbane project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$152 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2024 8:58AM |
$1.988 |
$1.780 |
fallen by
10.44%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- Interim Stage 2 clinical trial analysis confirms hyperacute and acute ischaemic stroke detection capabilities.
- Recruitment target for Stage 3 of the pre-validation clinical trial achieved with 30 haemorrhagic stroke patients.
- FDA pre-submission package under review.
- Pilot commercial production line for the emu™ brain scanner established.
- Fabrication of the First Responder (Gen 2) Proof of Concept device completed.
- Cash reserves of $18.66 million reported as of 30 June 2024.
- Receipt of final $1.25 million non-dilutive cash payment under the Modern Manufacturing Initiative grant.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$1,369 |
Weekly NTA - 26 July 2024
|
30 Jul 2024 8:58AM |
$10.330 |
$11.030 |
risen by
6.78%
|
|
| Race Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$212 |
Bisantrene Phase 2 AML Trial Successful Concludes
|
30 Jul 2024 8:57AM |
$1.605 |
$1.220 |
fallen by
23.99%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- The Phase 1b/2 trial of bisantrene in relapsed or refractory acute myeloid leukaemia (AML) was successfully concluded.
- 40% of patients showed a response to bisantrene combination treatment, surpassing the trial's predefined efficacy goal.
- Five patients had complete responses and one had a partial response.
- The clinical data supports initiating a new Phase 1/2 AML trial using RC220 bisantrene.
- The trial was conducted at Chaim Sheba Medical Centre in Israel under Professor Arnon Nagler.
- The trial used a Simon’s 2-stage design and included dose-escalation and efficacy stages.
- The trial results will be published in a peer-reviewed journal in 2024.
- Race Oncology plans to support a new investigator-sponsored AML clinical study using RC220 bisantrene.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$189 |
Update - Notification of buy-back - CDM
|
30 Jul 2024 8:56AM |
$0.715 |
$0.635 |
fallen by
11.19%
|
|
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$17 |
Growth Strategy Presentation
|
30 Jul 2024 8:55AM |
$0.053 |
$0.040 |
fallen by
24.53%
|
|
| Pentanet Limited (5GG) ORDINARY FULLY PAID |
Communication Services |
$12 |
Q4FY24 Results Investor Briefing Stream Details
|
30 Jul 2024 8:55AM |
$0.042 |
$0.027 |
fallen by
35.71%
|
|
| Pentanet Limited (5GG) ORDINARY FULLY PAID |
Communication Services |
$12 |
Q4FY24 Appendix 4C
|
30 Jul 2024 8:54AM |
$0.042 |
$0.027 |
fallen by
35.71%
|
|
5GG - Price-sensitive ASX Announcement
Full Release
Key Points
- Receipts from customers totaled $5.26 million.
- Net cash used in operating activities was $734,000.
- Invested $3.56 million in property, plant, and equipment.
- Spent $1.6 million for a 15-year high band 5G Spectrum license.
- Net cash inflow from financing activities was $156,000.
- Cash and cash equivalents at the end of the period were $5.3 million.
- Unused finance facilities available totaled $8.9 million.
- Total available funding is $14.2 million.
- Estimated quarters of funding available is 19.35.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$4 |
June 2024 Quarterly Activities and Cashflow Report
|
30 Jul 2024 8:53AM |
$0.003 |
$0.037 |
risen by
1,133.33%
|
|
PUR - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Drill Hole 1 at Maria Magdalena tenement with high-grade lithium assays.
- Commencement of Drill Hole 2 as part of Stage 1 Drill Program at RGS.
- Successful oversubscribed capital raising of $2.4 million AUD.
- $2.024 million in cash and equivalents available at quarter end.
- Start-up work and commissioning of the Lithium Carbonate Pilot Plant.
- Targeting a resource upgrade in the second half of 2024.
- Anticipated increase in Rio Grande Sur mineral resource.
- Planning for larger commercial operations and further drilling at the Mito tenement.
- Continuation of engineering and geological work for project feasibility study.
- Advancement of off-take discussions to support continuous production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$32 |
US$1.8m AnteoBind Purchase Agreement over 5 years
|
30 Jul 2024 8:53AM |
$0.022 |
$0.012 |
fallen by
45.45%
|
|
ADO - Price-sensitive ASX Announcement
Full Release
Key Points
- 5-year term of Agreement with US$370,000 minimum annual take or pay orders
- Product for use in vaccine development by Serum Institute of India
- Supply Agreement contains pricing to support the anticipated future increase in demand
- AnteoTech has existing capacity to meet the customer requirements
- Serum Institute of India produces over 1.5B vaccine doses and US$3B revenues annually
- First US$185,000 order for the Product received with shipment and payment in August
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$43 |
Quarterly Activities Report and Appendix 4C - June 2024
|
30 Jul 2024 8:52AM |
$0.595 |
$0.385 |
fallen by
35.29%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- First order received from Promega who is selling INOVIQ kits worldwide
- Breakthrough exosome therapy to target and kill breast cancer
- Successful analytical validation of SubB2M-CA125 ovarian cancer test
- EXO-NET Platform expands to isolating brain-derived exosomes for Alzheimer's Disease
- Capital raise of $9.4m under a placement to institutional and sophisticated investors
- Cash balance of $9.233m at 30 June 2024
- Completion of an analytical validation study for SubB2M blood test for ovarian cancer
- Development of NEU-CA125 test for better cancer detection
- Commercialisation of EXO-NET and progress in exosome programs
- Development of exosome therapeutics targeting cancer cells
- Investor events and successful completion of share purchase plan
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$40 |
TechKnow Invest Roadshow presentation and livestream links
|
30 Jul 2024 8:52AM |
$0.020 |
$0.029 |
risen by
45%
|
|
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$3 |
Geophysic confirms large magnetic targets - West Arunta
|
30 Jul 2024 8:51AM |
$0.100 |
$0.110 |
risen by
10%
|
|
LMS - Price-sensitive ASX Announcement
Full Release
Key Points
- 3.5km wide, pipe-shaped magnetic anomaly confirmed at Patmungala.
- Litchfield Minerals Limited has initiated a gravity survey program to further assess the anomaly.
- Northern Territory Geological Survey is supporting the deep drilling program with funding up to $140,000.
- Additional gravity survey to be completed over the Dumunzi target, north of Silver King.
- Soil sampling of selected targets will complement data acquisition for gravity surveys.
- Historical exploration identified significant base metal mineralization in the area.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Cashflow Report
|
30 Jul 2024 8:51AM |
$0.019 |
$0.008 |
fallen by
57.89%
|
|
LIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lion Energy Limited reported a net cash outflow from operating activities of USD 210,000 for the quarter ended 30 June 2024.
- Payments for development were USD 38,000 and production costs were USD 86,000.
- Staff costs totaled USD 93,000 and administration and corporate costs were USD 132,000.
- Lion Energy had no significant cash inflows from investing activities, with payments to acquire property, plant, and equipment amounting to USD 717,000.
- The company received proceeds from the issue of convertible debt securities totaling USD 1,046,000.
- Net cash from financing activities was USD 1,046,000, resulting in a net increase in cash and cash equivalents of USD 95,000 for the quarter.
- Cash and cash equivalents at the end of the period were USD 1,168,000.
- Lion Energy's share of joint venture cash held in operators' accounts at the end of the current quarter was USD 147,000.
- Payments to related parties and their associates included in operating activities amounted to USD 153,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Ethical Investment Limited (AEF) ORDINARY FULLY PAID |
Financials |
$682 |
AEF FY2024 Results Briefing - Invitation
|
30 Jul 2024 8:51AM |
$3.970 |
$6.010 |
risen by
51.39%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
